drugset / Trial / NCT01991951
Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation
RandomizedSingle-groupOpen-labelTreatment
Summary
We hypothesized that in patients with low CHADS-VASc score (2 or \< 2), there is no difference in thromboembolic or bleeding events between patients with short term warfarin therapy (2 weeks after catheter ablation) and conventional therapy (3 weeks before and 8 weeks after procedure).
Timeline
- Start
- 2013-07
- Primary completion
- 2015-07
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Warfarin | Small molecule | — | — |